Literature DB >> 11179724

Vitamin D receptor and nuclear receptor coactivators: crucial interactions in vitamin D-mediated transcription.

P N MacDonald1, T A Baudino, H Tokumaru, D R Dowd, C Zhang.   

Abstract

The nuclear actions of 1,25-dihydroxyvitamin D(3) [1alpha,25(OH)(2)D(3)] are mediated by the vitamin D receptor (VDR). Binding of ligand induces conformational changes in the VDR which promote heterodimerization with retinoid X receptor (RXR) and recruitment of a number of nuclear receptor coactivator proteins including the steroid receptor coactivator (SRC) family members, select SMAD proteins, a novel coactivator complex referred to as DRIP, and a variety of other putative factors. We recently described a novel nuclear receptor coactivator termed NCoA-62 that interacts with the VDR to enhance 1alpha,25(OH)(2)D(3)-activated transcription. NCoA-62 is unrelated to the SRC family, the DRIP complex, as well as other nuclear receptor coactivators described thus far. The molecular mechanisms involved in NCoA-62 coactivator function are poorly understood, but protein-protein interactions are likely to play an important role. The purpose of this paper is to briefly review salient features of the coactivators involved in VDR-activated transcription and to focus on our current understanding of NCoA-62 and its interplay with other nuclear receptor coactivator proteins. It is clear from the studies described here that a concerted series of interactions with multiple coactivator proteins are essential for high order transactivation by 1alpha,25(OH)(2)D(3) and the VDR.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179724     DOI: 10.1016/s0039-128x(00)00200-2

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  20 in total

Review 1.  Immunomodulation by vitamin D: implications for TB.

Authors:  Rene F Chun; John S Adams; Martin Hewison
Journal:  Expert Rev Clin Pharmacol       Date:  2011-09       Impact factor: 5.045

Review 2.  The biology and pathology of vitamin D control in bone.

Authors:  Taison D Bell; Marie B Demay; Sherri-Ann M Burnett-Bowie
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

3.  Fluorescence polarization assays in high-throughput screening and drug discovery: a review.

Authors:  Matthew D Hall; Adam Yasgar; Tyler Peryea; John C Braisted; Ajit Jadhav; Anton Simeonov; Nathan P Coussens
Journal:  Methods Appl Fluoresc       Date:  2016-04-28       Impact factor: 3.009

Review 4.  Nuclear receptors in neural stem/progenitor cell homeostasis.

Authors:  Dimitrios Gkikas; Matina Tsampoula; Panagiotis K Politis
Journal:  Cell Mol Life Sci       Date:  2017-06-21       Impact factor: 9.261

5.  Thyroid cancer resistance to vitamin D receptor activation is associated with 24-hydroxylase levels but not the ff FokI polymorphism.

Authors:  Vibha Sharma; Deborah Fretwell; Zachary Crees; Anna Kerege; Joshua P Klopper
Journal:  Thyroid       Date:  2010-10       Impact factor: 6.568

6.  Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase.

Authors:  Puneet Dhawan; Xiaorong Peng; Amelia L M Sutton; Paul N MacDonald; Colleen M Croniger; Christian Trautwein; Michael Centrella; Thomas L McCarthy; Sylvia Christakos
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

7.  MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription.

Authors:  Sandra Laduron; Rachel Deplus; Sifang Zhou; Olga Kholmanskikh; Danièle Godelaine; Charles De Smet; S Diane Hayward; François Fuks; Thierry Boon; Etienne De Plaen
Journal:  Nucleic Acids Res       Date:  2004-08-17       Impact factor: 16.971

Review 8.  New Vitamin D analogues for osteodystrophy in chronic kidney disease.

Authors:  John Cunningham
Journal:  Pediatr Nephrol       Date:  2004-05-13       Impact factor: 3.714

9.  Inhibition of protein kinase CK2 reduces Cyp24a1 expression and enhances 1,25-dihydroxyvitamin D(3) antitumor activity in human prostate cancer cells.

Authors:  Wei Luo; Wei-Dong Yu; Yingyu Ma; Mikhail Chernov; Donald L Trump; Candace S Johnson
Journal:  Cancer Res       Date:  2013-01-28       Impact factor: 12.701

10.  Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2.

Authors:  Michihiko Usui; Lianping Xing; Hicham Drissi; Michael Zuscik; Regis O'Keefe; Di Chen; Brendan F Boyce
Journal:  J Bone Miner Res       Date:  2008-03       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.